Feasibility and Therapeutic Potential of Combined Peptide Receptor Radionuclide Therapy With Intensive Chemotherapy for Pediatric Patients With Relapsed or Refractory Metastatic Neuroblastoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Feasibility and Therapeutic Potential of Combined Peptide Receptor Radionuclide Therapy With Intensive Chemotherapy for Pediatric Patients With Relapsed or Refractory Metastatic Neuroblastoma

Published:2021-03-16 Issue: Volume:Publish Ahead of Print Page:
ISSN:0363-9762
Container-title:Clinical Nuclear Medicine
language:en
Short-container-title:

Author:

Fathpour Gholamreza,Jafari Esmail,Hashemi Arman,Dadgar Habibollah,Shahriari Mahdi,Zareifar Soheila,Jenabzade Ali Reza,Vali Reza,Ahmadzadehfar Hojjat,Assadi Majid

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Radiology Nuclear Medicine and imaging,General Medicine

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances and impending challenges for the radiopharmaceutical sciences in oncology;The Lancet Oncology;2024-06

2. Production of the state of the art therapeutic radiopharmaceuticals in Iran, from beta- to alpha-emitting targeted radionuclide therapy: Clinical advances and perspectives;IRAN J NUCL MED;2024

3. Current Status and Future Perspective on Molecular Imaging and Treatment of Neuroblastoma;Seminars in Nuclear Medicine;2023-07

4. Lutathera® Orphans: State of the Art and Future Application of Radioligand Therapy with 177Lu-DOTATATE;Pharmaceutics;2023-03-31

5. Feasibility and therapeutic potential of the 68Ga/177Lu-DOTATATE theranostic pair in patients with metastatic medullary thyroid carcinoma;Annales d'Endocrinologie;2023-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP